Gentas become a resident of JLABS @ Shanghai on Mar 2nd, 2021

We are pleased to announce that Gentas Biotechnology has recently become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai (‘JLABS’).  By leveraging JLABS’ global network and resources, we hope to be able to accelerate our goals of utilizing unique swine platforms for drug R&D and for advancing gene therapy strategies via Proof-of-Concept (POC) studies. We are confident that we will be able to expediate our innovative programs and bring potential healthcare solutions to patients quickly.

JLABS is a premier life science incubator program. JLABS is a global network of open innovation ecosystems, which aims to enable and empower innovators to create and accelerate the delivery of potential life-enhancing health and wellness solutions to patients around the world.